José Ignacio Rivero and Jacinto Ávalos (slider)

Pérez-Llorca assists GVS in acquisition of Haemonetics blood business

Pérez-Llorca Mexico has assisted GVS in its strategic acquisition of the whole blood business of Haemonetics Corporation.

GVS, based in Italy, is a global leader in advanced filtration solutions, with a strong presence in multiple industries, including healthcare, life sciences and industrial applications. GVS is listed on the Italian stock exchange.

Haemonetics Corporation, headquartered in the United States, is a global leader in innovative products and services. Haemonetics is listed on the New York Stock Exchange (NYSE).

This transaction involved the acquisition of assets in multiple jurisdictions, including Mexico, the US and Italy. A key component was the transfer of assets subject to the maquila regime in ‘Mexico’ and their complex structuring.

The transaction closed on 14 January and had a value of up to USD 66 million. DLA Piper acted as Italian, US and Mexican counsel to Haemonetics Corporation, while Cleary Gottlieb Steen & Hamilton advised GVS in Italy and the US.

Pérez-Llorca’s team included partners José Ignacio Rivero (pictured left), Jacinto Ávalos Capín (pictured right) and Christian Kaye Trueba, senior associate Raúl Paniahua Reyes, associates Héctor Ferrari Ruiz and María Angélica Domínguez Prado, and counsel Félix Ponce-Nava Cortes.

L Giselle Estrada

SHARE